Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 4/20 | 0.78 |
| ▸ | NAALAD2 | Q9Y3Q0 | 10/20 | 0.62 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | FTO | Q9C0B1 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13286293 | 0.88 | ALB (1.00) | ALBNAALAD2FTO | |
| SCHEMBL24910527 | 0.83 | NAALAD2 (0.66) | ALBNAALAD2FOLH1NR1H2KEAP1 | |
| SCHEMBL9881740 | 0.81 | NAALAD2 (0.64) | ALBNAALAD2FOLH1FTO | |
| SCHEMBL24910738 | 0.81 | NAALAD2 (0.63) | ALBNAALAD2FOLH1NR1H2KEAP1 | |
| SCHEMBL22863222 | 0.80 | FTO (0.62) | NAALAD2FOLH1FTO | |
| SCHEMBL8699727 | 0.80 | FTO (0.60) | ALBNAALAD2FTO | |
| SCHEMBL12946728 | 0.78 | ALB (0.81) | ALBNAALAD2FOLH1FTO | |
| SCHEMBL15943022 | 0.77 | FTO (0.61) | NAALAD2FTO | |
| SCHEMBL22863319 | 0.76 | NAALAD2 (0.63) | NAALAD2NR1H2KEAP1FTO | |
| SCHEMBL25711649 | 0.76 | NAALAD2 (0.60) | ALBNAALAD2NR1H2KEAP1FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100172844-A1 | ALBUMIN BINDING MOLECULES AND USES THEREOF | PHILOCHEM AG (CH) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100172844-A1 | ALBUMIN BINDING MOLECULES AND USES THEREOF | ALB, FABP1, FABP2 | ALB 1/4885NAALAD2 137/4885FOLH1 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.